Liver Disease: Buprenorphine, Methadone, and Smoking Cessation Agents
From Psychopharmacology and Psychiatry Updates · · 11 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Faculty: Kevin A. Sevarino, M.D.C.M., Ph.D. Host: Flavio Guzmán, M.D.
- Learn more about our memberships here
- Earn 1.25 CME: Addiction Psychopharmacology in Patients with Medical Comorbidities
- Liver Disease: Buprenorphine, Methadone, and Smoking Cessation Agents
Back to Psychopharmacology and Psychiatry Updates · Report a problem